Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 451–500 of 1,846 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05668767	Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC	unknown	Phase 2	20	Beijing Chest HospitalOTHER	0	Dec 30, 2022	clinicaltrials
NCT04049942	Comparing the Impact of Multimodal Prehabilitation to Aerobic Training on Patients Undergoing Thoracoscopic Lobectomy	unknown	N/A	100	Peking Union Medical College HospitalOTHER	1	Dec 28, 2022	clinicaltrials